Anti-HIV therapy: A pharmaceutical mixture encompassing etoposide and idasanutlin(ESIA) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production, via upregulation of its target gene, 13/March/2019, 10.39 pm